|Articles|May 5, 2008

To speed claims processing, payers should allow a non-NPI prescriber ID

The Centers for Medicare & Medicaid Services has issued an FAQ that explains about the use of a non-NPI for prescribers who are not covered entities.

Payers can work with pharmacies to come up with a non-national provider identifier or default alternative on billing transactions for physicians who do not use an NPI. In an FAQ #9100, the Centers for Medicare & Medicaid Services explained that some physicians are not covered entities and do not require an NPI. In such cases, a pharmacy can use a non-NPI prescriber ID if allowed by the payer. However, CMS cautioned that this default should be used only in rare cases.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, .

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Latest CME

$Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists$

Patient First: Delivering Value with Clinical & Preventive Services

To speed claims processing, payers should allow a non-NPI prescriber ID

Related Content

The Pharmacist’s Role Amid Measles Surge, Vaccine Policy Change

Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide

Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%

Measles Resurgence Exposes US Vaccine Policy Risks, Experts Warn

Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination

Latest CME

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

The Pharmacist's Role in Palliative and End of Life Symptom Management (Pharmacy Technician Credit)

The Pharmacist's Role in Palliative and End of Life Symptom Management

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians (Pharmacy Technician Credit)

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

Exploring Oncolytic Viruses in Melanoma: Pharmacist-Led Approaches for Safe Integration

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Reducing the Treatment Burden in HIV Management: The Pharmacist’s Role in Long-Acting Injectable Adoption

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

Addressing Vaccine Hesitancy in Infectious Disease Prevention

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelines Into Managed Care Strategies

From Guidelines to Action: Implementing Pneumococcal Vaccine ACIP Recommendations in Long-Term Care Settings

Influenza Immunization in Older Adults: Enhanced Vaccines and Best Practices for Long-Term Care Pharmacists

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Trending on Drug Topics

Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide

Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination

Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%

Zepbound Lowers Health Care Costs in Older Adults With Obesity

Measles Resurgence Exposes US Vaccine Policy Risks, Experts Warn